Overall, our findings identify BMP6 as a distinct and promising multi-functional regulator with the capacity to promote bone formation, limit bone resorption, and attenuate stromal support of tumor growth in multiple myeloma, supporting its further investigation as a potential therapeutic approach for myeloma bone disease. The gene discussed is BMP6; the disease is AL amyloidosis.